Femoral Head Avascular Necrosis Workup

  • Author: John D Kelly IV, MD; Chief Editor: Sherwin SW Ho, MD   more...
 
Updated: Feb 28, 2010
 

Laboratory Studies

  • Routine laboratory studies are of little value in the evaluation of femoral head AVN other than to rule out other conditions that may cause hip pain (eg, rheumatoid arthritis). (See also the eMedicine articles Rheumatoid Arthritis [in the Physical Medicine and Rehabilitation section], Rheumatoid Arthritis [in the Rheumatology section], and Juvenile Rheumatoid Arthritis [in the Pediatrics section], as well as the Rheumatoid Arthritis Resource Center on Medscape.)
    • Hematologic studies may reveal sickle cell disease, if clinically suspected. (See also the eMedicine articles Sickle Cell Anemia [in the Pediatrics section] and Pediatrics, Sickle Cell Disease [in the Emergency Medicine section].)
    • Subtle coagulation disturbances (eg, hypofibrinolysis, thrombophilia) are frequent findings, but the significant cost and limited availability of the sophisticated coagulation tests that are necessary for these diagnoses argue against routine screening.
Next

Imaging Studies

  • Plain radiographs
    • Obtain anteroposterior and frog-leg lateral views of both hips. The high incidence of bilaterality (>60%) and occult disease in cases of femoral head AVN warrant imaging of the unaffected leg.
    • Early radiographic findings include femoral head lucency and subchondral sclerosis.
    • With disease progression, subchondral collapse (ie, crescent sign) and femoral head flattening become evident radiographically. Joint space narrowing is the end result of untreated femoral head AVN.
    • Radiographic staging of AVN was first proposed by Ficat and Arlet in the 1960s and later amended in the 1970s.[5] This 4-stage system delineates the natural history of AVN from normal radiographs (stage I) to cystic changes and sclerosis (stage II), to subchondral collapse or femoral head flattening (stage III), and finally to joint space narrowing (stage IV). However, this system does not differentiate among certain phases in disease progression (eg, subchondral vs femoral head collapse), nor does it quantify the size and extent of the lesion.
    • Steinberg proposed the following staging system, known as the Steinberg Classification System, which is concise and delineates the progression and extent of AVN involvement more accurately.[6, 7] This staging system has gained increasing acceptance in the orthopedic community.
      • Stage I – Normal radiographs; abnormal MRI or bone scan
      • Stage II – Abnormal lucency or sclerotic site in femoral head
      • Stage III – Subchondral collapse (ie, crescent sign) without flattening of femoral head
      • Stage IV – Flattening of the femoral head; normal joint space
      • Stage V – Joint space narrowing, acetabular changes, or both
      • Stage VI – Advanced degenerative changes
      • Stages I-IV are further subdivided according to the percentage of femoral head involvement: A (< 15%), B (15-30%), or C (>30%).
  • MRI
    • MRI is the study of choice in patients who demonstrate signs and symptoms that are suggestive of AVN but whose radiographs are normal.
    • MRI is the most sensitive and specific means of diagnosing AVN. MRI may detect disease as early as 5 days subsequent to an ischemic insult.
    • Characteristic MRI findings for AVN of the hip include a low signal intensity band (seen on T1 and T2 images) that demarcates a necrotic anterosuperior femoral head segment. The extent and location of femoral head necrosis on MRIs have been studied as predictors of femoral head collapse. Smaller lesions (less than one fourth the diameter of the femoral head) and more medial lesions (away from primary weight-bearing areas) predict a better outcome.[7]
  • Bone scanning
    • Abnormalities may show up on a bone scan before they do on plain radiographs. Bone scan findings should be supplemented with MRI findings.
    • The presence of a photopenic area that is surrounded by increased tracer uptake is the typical scintigraphic picture for radionuclide imaging.
    • Bone scans are considerably less sensitive and less specific than MRI, but the images may be useful if the use of MRI is contraindicated.
  • Computed tomography (CT) scanning
    • CT scans confer significant radiation exposure to the patient and are less sensitive than MRI in diagnosing AVN.
    • CT scanning may help delineate early subchondral collapse because the resolution of bony architecture with this modality is unsurpassed.
  • Angiography is an invasive mean of diagnostic confirmation of AVN; it is most useful as an investigational modality.
Previous
Next

Procedures

  • Biopsy, angiography, and measuring bone marrow pressure are invasive measures of confirming the diagnosis of AVN, but these procedures are most useful as investigational modalities.
Previous
 
 
Contributor Information and Disclosures
Author

John D Kelly IV, MD  Associate Professor, Department of Orthopedic Surgery, University of Pennsylvania, Consulting Surgeon Shriner's Hospital for Surgery

John D Kelly IV, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American Orthopaedic Society for Sports Medicine, Arthroscopy Association of North America, Eastern Orthopaedic Association, Pennsylvania Orthopaedic Society, and Philadelphia County Medical Society

Disclosure: Nothing to disclose.

Coauthor(s)

David Wald, DO, FACOEP  Assistant Program Director, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Temple University School of Medicine

David Wald, DO, FACOEP is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Gerard A Malanga, MD  Director of Pain Management, Overlook Hospital; Director of PM&R Sports Medicine Fellowship, Atlantic Health; Clinical Professor, Department of Physical Medicine and Rehabilitation, UMDNJ-New Jersey Medical School; Clinical Chief, Rehabilitation Medicine and Electrodiagnosis, St Michael's Medical Center; Fellow, American College of Sports Medicine

Gerard A Malanga, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Physical Medicine and Rehabilitation, American College of Sports Medicine, North American Spine Society, and Physiatric Association of Spine, Sports and Occupational Rehabilitation

Disclosure: Cephalon Honoraria Speaking and teaching; Endo Honoraria Speaking and teaching; Forest Labs Honoraria Speaking and teaching

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Jon B Whitehurst, MD  Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital

Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America

Disclosure: Nothing to disclose.

Chief Editor

Sherwin SW Ho, MD  Associate Professor, Department of Surgery, Section of Orthopedic Surgery and Rehabilitation Medicine, University of Chicago

Sherwin SW Ho, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America

Disclosure: Nothing to disclose.

References
  1. Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg. Jul-Aug 1999;7(4):250-61. [Medline].

  2. Vail TP, Covington DB. The incidence of osteonecrosis. In: Urbaniak JR, Jones JR, eds. Osteonecrosis: Etiology, Diagnosis, Treatment. Rosemont, Ill: American Academy of Orthopedic Surgeons; 1997:43-9.

  3. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. Mar 1995;77(3):459-74. [Medline].

  4. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. May 2001;386:173-8. [Medline].

  5. Arlet J, Ficat P. [Non-traumatic avascular femur head necrosis. New methods of examination and new concepts] [Polish]. Chir Narzadow Ruchu Ortop Pol. 1977;42(3):269-76. [Medline].

  6. Steinberg ME. Avascular necrosis: diagnosis, staging, and management. J Musculoskel Med. 1997;14(11):13-25.

  7. Steinberg ME. Diagnostic imaging and the role of stage and lesion size in determining outcome in osteonecrosis of the femoral head. Techniques in Orthopaedics. Mar 2001;16(1):6-15. [Full Text].

  8. McGrory BJ, York SC, Iorio R, et al. Current practices of AAHKS members in the treatment of adult osteonecrosis of the femoral head. J Bone Joint Surg Am. Jun 2007;89(6):1194-204. [Medline].

  9. Ciombor DM, Aaron RK. Biologically augmented core decompression for the treatment of osteonecrosis of the femoral head. Techniques in Orthopaedics. Mar 2001;16(1):32-8. [Full Text].

  10. Katz MA, Urbaniak JR. Free vascularized fibular grafting of the femoral head for the treatment of osteonecrosis. Techniques in Orthopaedics. Mar 2001;16(1):44-60. [Full Text].

  11. McCarthy J, Puri L, Barsoum W, et al. Articular cartilage changes in avascular necrosis: an arthroscopic evaluation. Clin Orthop Relat Res. Jan 2003;406:64-70. [Medline].

  12. Ivankovich DA, Rosenberg AG, Malamis A. Reconstructive options for osteonecrosis of the femoral head. Techniques in Orthopaedics. Mar 2001;16(1):66-79. [Full Text].

  13. Squire M, Fehring TK, Odum S, Griffin WL, Bohannon Mason J. Failure of femoral surface replacement for femoral head avascular necrosis. J Arthroplasty. Oct 2005;20(7 suppl 3):108-14. [Medline].

  14. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. Jun 2005;435:164-70. [Medline].

  15. [Best Evidence] Lai KA, Shen WJ, Yang CY, et al. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. Oct 2005;87(10):2155-9. [Medline].

  16. DeLee JC. Fractures and dislocations of the hip. In: Rockwood CA, Green DP, Bucholz RW, eds. Rockwood and Green's Fractures in Adults. 4th ed. Philadelphia, Pa: Lippincott-Raven; 1996:1661-9.

  17. Etienne G, Mont MA, Khanuja HS, Hungerford DS. Nonvascularized bone grafts for osteonecrosis of the femoral head: current concepts and techniques. Techniques in Orthopaedics. Mar 2001;16(1):39-43. [Full Text].

  18. Kim SY, Kim YG, Kim PT, et al. Vascularized compared with nonvascularized fibular grafts for large osteonecrotic lesions of the femoral head. J Bone Joint Surg Am. Sep 2005;87(9):2012-8. [Medline].

  19. Urbaniak JR, Barnes CJ. Meeting the challenge of osteonecrosis in adults. J Musculoskel Med. 2001;18:395-403.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.